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Alcohol Use Disorder (AUD) alone effects nearly 6% of 
the adult population within the United States. Few 
treatments for AUD exist, with no new FDA-approved 
therapeutic treatments within the last 15 years. 
Additionally, the limited treatments we do have are 
estimated to produce sustained abstinence in less than 
20% of individuals.
Psychedelics, such as lysergic acid diethylamide 
(LSD), psilocybin and 2,5-dimethoxy-4-
iodoamphetamine (DOI) affect processes related to 
cognition, perception and sensory processing. These 
compounds are serotonergic agonists and act primarily 
through the 5-HT2A receptor in the frontal cortex.
It has been demonstrated that serotonin has 
modulatory effects on the mesolimbic pathway, which is 
implicated in the neurobiology of addiction.
Clinical findings have demonstrated the ability of 
psilocybin to decrease alcohol consumption in heavy 
drinkers and studies with rodent models have 
suggested DOI and LSD have the ability to decrease 
ethanol preference and consumption.
The present study aims to evaluate the effects of 
psychedelic, 2,5-dimethoxy-4-iodoamphetamine (DOI), 
on ethanol drinking behavior in adult male C57BL/6 
mice.
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Methodology
Subjects 15 adult male C57BL/6 mice were kept on a reverse 
light cycle and had food and water ad libitum.
Training Mice were trained on the two-bottle choice paradigm by 
being given access to one bottle of 20% ethanol and one bottle
of water every other day (off days mice had two bottles of water) 
for four weeks to obtain a baseline reading of drinking behavior. 
Following these four weeks, mice were assigned to either the 
treatment group or vehicle group based on weight and baseline 
drinking behavior from the week prior to testing. 
Testing On the first day of the fifth and sixth weeks, mice were 
injected intraperitoneally with a dose of DOI (2 or 5 mg/kg) or 
saline vehicle 30-minutes prior to access to 20% ethanol. These 
DOI doses were chosen based on previous behavioral studies 
and dose response curves. Ethanol was given using 15 ml glass 
bottles with rubber stoppers. Liquid volumes were recorded prior 
to putting bottles in the cages.
Results
Figure 1. Effects of a moderate  and high dose of DOI  on ethanol 
preference and consumption. Dotted lines represent injection of 2 
mg/kg DOI on drinking Day 14 (start of week 5) and 5 mg/kg DOI on 
Day 17 (start of week 6). 
Figure 3. Comparison of average consumption, preference and 
total fluid consumption for baseline, 2 mg/kg and 5 mg/kg DOI. 
(Two-way ANOVA with multiple comparisons; α<0.05).
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References
Conclusion
We hypothesized that a moderate dose of DOI would 
decrease ethanol preference and consumption.
• DOI did not affect ethanol consumption or preference at the 2- or 
24-hour measures compared to baseline (week prior to DOI 
injection).
• The DOI-treated group showed no difference from the vehicle-
treated group after receiving an either moderate (2 mg/kg) or 
high (5 mg/kg) dose of DOI. 
• There was an overall interaction of time and treatment in both 2-
and 24-hour fluid consumption in the groups (2-way ANOVA; 2-h 
total fluid [p=0.0343] and 24-h total fluid [p=0.0112]).
• Our results are most likely due to:
• Issues with group randomization - Mice were assigned 
a group based on weights and average drinking values 
from the last drinking day prior to the first DOI treatment 
week.
• Not allocating the mice into low and high drinking 
groups as seen is other experimental designs
• Further statistical analysis to determine the relationship of the 
baseline behavior to the behavior seen following DOI needs to 
be completed for further interpretation of results.
• More experiments are warranted before fully understanding how 
psychedelics can alter behavioral phenotypes associated with 
substance use disorder and alcoholism.
Measurements The amount of both water and ethanol consumed 
on drinking days was measured at 2- and 24-hours and analyzed 
to calculate consumption and preference. Empty cages containing 
bottles of both ethanol and water were used as a measure of 
bottle leaks or evaporation. Raw consumption values were 
corrected and converted into preference percentages. Total fluid 
consumption was also calculated.
Data analysis All statistical analysis was done using GraphPad 
Prism version 9.0.
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